Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

646
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
646
Survival Curves01:18

Survival Curves

344
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
344
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

284
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
284
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

306
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
306
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

588
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
588
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

202
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
202

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticocortical evoked potential amplitude is altered by cortical stimulation in epilepsy.

Epilepsia·2026
Same author

Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank.

Journal of the American Heart Association·2026
Same author

Social Disadvantage and Disparities in Chronic Liver Disease: A Systematic Review.

The American journal of gastroenterology·2024
Same author

Dynamic risk prediction of survival in liver cirrhosis: A comparison of landmarking approaches.

PloS one·2024
Same author

Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.

Cytotherapy·2023
Same author

Designing superiority trials with window mean survival time as a primary endpoint.

Statistics in medicine·2023

Related Experiment Video

Updated: Sep 22, 2025

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K

Versatile tests for window mean survival time.

Mitchell Paukner1, Richard Chappell1,2

  • 1Department of Statistics, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Statistics in Medicine
|May 25, 2022
PubMed
Summary

This study introduces versatile tests for Window Mean Survival Time (WMST) to improve survival analysis in oncology trials. These new methods offer enhanced power and interpretation compared to traditional WMST, especially with immunotherapy data.

Keywords:
logrank testnonproportional hazardssurvival dataweighted rank test

More Related Videos

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Sep 22, 2025

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Analysis
  • Survival Analysis

Background:

  • Window Mean Survival Time (WMST) is a flexible extension of restricted mean survival time for assessing survival differences within specific time windows.
  • Traditional WMST requires pre-specified window bounds, and misspecification can lead to reduced statistical power and less meaningful interpretations.
  • There is a need for more robust statistical methods to analyze survival data in clinical trials, particularly in oncology.

Purpose of the Study:

  • To introduce versatile statistical tests for Window Mean Survival Time (WMST).
  • To address the limitations of traditional WMST by utilizing multiple WMST statistics simultaneously.
  • To provide a more powerful and interpretable method for survival analysis in clinical trials, especially in oncology.

Main Methods:

  • Development of versatile tests based on the simultaneous use of multiple WMST test statistics.
  • Asymptotic normality of the proposed test statistics under the null hypothesis of no difference between groups.
  • Monte Carlo simulations to evaluate the power of the new tests in various scenarios, including moderate sample sizes and different censoring levels.

Main Results:

  • The proposed versatile WMST tests demonstrate good power in simulations, even with moderate sample sizes and heavy censoring.
  • The methods are shown to be effective in survival scenarios common in oncology, including those relevant to immunotherapy trials.
  • The study provides practical implementation guidance through real data examples.

Conclusions:

  • The versatile WMST tests offer an improvement over traditional methods, providing enhanced statistical power and interpretability.
  • These new methods are valuable tools for analyzing survival data in clinical trials, particularly in oncology.
  • The associated R package, survWMST, facilitates the application of these versatile tests.